Overview

Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Nesiritide is more effective than nitroglycerin in modifying inflammatory and neurohormonal biomarkers without renal toxicity when proper infusion duration is administered.
Phase:
Phase 4
Details
Lead Sponsor:
Western University of Health Sciences
Collaborator:
American College of Clinical Pharmacy
Treatments:
Natriuretic Peptide, Brain
Nitroglycerin